A dose of private equity is apparently just what the doctor ordered. On Tuesday, UK-based PE firm Vitruvian Partners made a $ 637 million strategic investment in DeepIntent, a health care-focused demand-side platform that specializes in helping pharma brands reach patients and providers using programmatic advertising. Although Vitruvian’s portfolio includes a bunch of software, consumer tech […]
The post Health Care DSP DeepIntent Sells $ 637 Million Majority Stake To PE Firm Vitruvian Partners appeared first on AdExchanger.
More Stories
Together launches Discovery practice
How Halo Collar Uses Data And Incrementality To Raise Both Awareness And Sales
2026 YouTube NZ Marketing Awards celebrate every angle